Carter statement on FTC suing PBMs over high insulin prices
September 20, 2024
September 20, 2024
WASHINGTON, Sept. 20 -- Rep. Earl L. Carter, R-Georgia, issued the following news release:
Rep. Earl L. "Buddy" Carter (R-GA), a pharmacist by trade, issued the following statement after the Federal Trade Commission (FTC) today sued the nation's largest pharmacy benefit managers (PBMs) Optum Rx, Caremark, and Express Scripts and their respective group purchasing organizations for spiking insulin prices, imperiling the health of over 8 million Americans:
" . . .
Rep. Earl L. "Buddy" Carter (R-GA), a pharmacist by trade, issued the following statement after the Federal Trade Commission (FTC) today sued the nation's largest pharmacy benefit managers (PBMs) Optum Rx, Caremark, and Express Scripts and their respective group purchasing organizations for spiking insulin prices, imperiling the health of over 8 million Americans:
" . . .